DEVELOPING NEW ADVANCED

DIAGNOSTIC SOLUTIONS

to help patients make better decisions

 

RESEARCH & DISCOVERIES

Atturos is a fast growing clinical diagnostics company developing molecular diagnostic tests to support better patient decisions. Currently focusing on the identification of serum protein biomarkers, Atturos uses cutting edge technology in collaboration with key clinical consortia and big pharma.  

Patient driven molecular diagnostics

WHAT WE DO

Atturos is a University College Dublin (UCD) spin out company founded in 2014 specifically with the intention of commercialising the OCProDx test. Atturos is a company based on sophisticated science with patient well-being at its core. The first product we are developing is a simple blood test to determine whether or not diagnosed prostate cancer is confined to the prostate. With this information, patients can have an informed role in their choice of treatment, including the opportunity of patient monitoring via active surveillance. This aims to prevent unnecessary over treatment of a disease that most patients will not die from. The test itself is performed on a robust clinical platform using advanced proteomics methods and state-of-the-art equipment. Atturos has a highly experienced and committed initial leadership team who have the support of a wide network of commercial, clinical and scientific advisors. 

PROUDLY COLLABORATING WITH

©2020 Atturos Ltd.